Federal Register / Vol. 89, No. 227 / Monday, November 25, 2024 / Notices 92943 

Portal Discharge Tab, presented as an 

appendix to the form. 

Æ Add ‘‘Concurrent Planning: 

Additional Potential Sponsors’’ segment 

to Family Reunification Section with 

the following fields (which will autopopulate from the Sponsor Assessment 

(Form S–5, currently approved under 

this information collection): 

D Potential Sponsor Name. 

D Relationship to Child. 

D Sponsor Category. 

Æ Split the ‘‘Know Your Rights 

Presentation and Legal Screening’’ into 

two distinct fields to capture the 

completion date for each more 

accurately, acknowledging that they 

typically are not completed on the same 

day. 

Æ Add ‘‘Back-Up Case Manager’’ 

segment to Case Manager Information 

Section to designate an alternative Case 

Manager who may take actions on 

behalf of the primary Case Manager 

when they are unavailable. The 

corresponding fields mirror those for 

primary case manager and will either be 

system-generated or auto-populate with 

user account data already entered the 

system. The fields include: 

D Back-up Case Manager Name. 

D Back-up Case Manager Email 

Address. 

D Back-up Case Manager Phone 

Number. 

D Back-up Case Manager 

Organization. 

D Assigned on (MM/DD/YYYY). 

Æ Adjust the burden estimate to 

account for an increase in the number 

of care provider facilities and number of 

children placed in ORR care, as well as 

the addition of the above listed new 

segments and fields. The annual number 

of respondents increased from 216 to 

300, the annual number of responses per 

respondent increased from 278 to 327, 

and the average burden hours per 

response increased from 0.08 hours to 

0.25 hours. 

Respondents: ORR grantee and 

contractor staff. 

Annual Burden Estimates: 

ANNUAL BURDEN ESTIMATE FOR RESPONDENTS

Form 

Annual 

number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden hours 

per response 

Annual total 

burden hours 

Foster Care Travel Req. Form (S–14) ............................................................ 138 178 0.25 6,141 

Admission (S–18) ............................................................................................ 300 327 0.33 32,373

UC Authorized/Restricted Call List and Call Log (S–20) ................................ 300 15,711 0.08 377,064 

Case Manager Call Log and Case Notes (S–23) ........................................... 300 8,183 0.08 196,392 

UC Case Status (S–27) ................................................................................... 300 327 0.25 24,525 

Estimated Annual Burden Hours Total ..................................................... ........................ ........................ ........................ 636,495 

Comments: The Department 

specifically requests comments on (a) 

whether the proposed collection of 

information is necessary for the proper 

performance of the functions of the 

agency, including whether the 

information shall have practical utility; 

(b) the accuracy of the agency’s estimate 

of the burden of the proposed collection 

of information; (c) the quality, utility, 

and clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Consideration will be given 

to comments and suggestions submitted 

within 60 days of this publication. 

Authority: 6 U.S.C. 279; 8 U.S.C. 

1232. 

Mary C. Jones, 

ACF/OPRE Certifying Officer. 

[FR Doc. 2024–27505 Filed 11–22–24; 8:45 am] 

BILLING CODE 4184–45–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2018–N–0180] 

Agency Information Collection 

Activities; Submission for Office of 

Management and Budget Review; 

Comment Request; Generic Clearance 

for the Collection of Quantitative Data 

on Tobacco Products and 

Communications 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing 

that a proposed collection of 

information has been submitted to the 

Office of Management and Budget 

(OMB) for review and clearance under 

the Paperwork Reduction Act of 1995. 

DATES: Submit written comments 

(including recommendations) on the 

collection of information by December 

26, 2024. 

ADDRESSES: To ensure that comments on 

the information collection are received, 

OMB recommends that written 

comments be submitted to https://

www.reginfo.gov/public/do/PRAMain. 

Find this particular information 

collection by selecting ‘‘Currently under 

Review—Open for Public Comments’’ or 

by using the search function. The OMB 

control number for this information 

collection is 0910–0810. Also include 

the FDA docket number found in 

brackets in the heading of this 

document. 

FOR FURTHER INFORMATION CONTACT: 

JonnaLynn Capezzuto, Office of 

Operations, Food and Drug 

Administration, Three White Flint 

North, 10A–12M, 11601 Landsdown St., 

North Bethesda, MD 20852, 301–796– 

3794, PRAStaff@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: In 

compliance with 44 U.S.C. 3507, FDA 

has submitted the following proposed 

collection of information to OMB for 

review and clearance. 

Generic Clearance for the Collection of 

Quantitative Data on Tobacco Products 

and Communications 

OMB Control Number 0910–0810— 

Extension 

This information collection supports 

FDA programs. Under section 

1003(d)(2)(D) of the Federal Food, Drug, 

and Cosmetic Act (21 U.S.C. 

393(d)(2)(D)), FDA is authorized to 

conduct educational and public 

information programs. Under this 

umbrella, FDA’s Center for Tobacco 

Products (CTP) conducts research and 

uses a variety of media to inform and 


khammond on DSK9W7S144PROD with NOTICES
92944 Federal Register / Vol. 89, No. 227 / Monday, November 25, 2024 / Notices 

educate stakeholders (e.g., the public, 

tobacco retailers, and health 

professionals) about the risks of tobacco 

use, how to quit using tobacco products, 

and FDA’s role in regulating tobacco. 

To ensure that these educational and 

public information programs have the 

highest potential to be received, 

understood, and accepted by those for 

whom they are intended, CTP conducts 

research to understand and identify and 

develop health messages relating to the 

control and prevention of disease. In 

conducting such research, FDA uses 

quantitative methods for studies about 

tobacco products, including but not 

limited to surveys, experimental 

studies, quasi-experimental studies, and 

the collection and analysis of digital 

metrics. These studies are used to 

collect information related to 

foundational research informing 

message development; formative 

pretesting of tobacco communication 

messages and other materials directed at 

consumers; understanding the impact of 

tobacco public education materials in 

the digital environment; awareness of 

and receptivity to tobacco public 

education materials; and developing 

and testing survey measures to inform 

future research. 

This type of research may involve: (1) 

assessing audience knowledge, 

attitudes, intentions, behaviors, and 

other characteristics for the purpose of 

determining the need for and 

developing health messages, 

communication strategies, 

dissemination strategies, and public 

information programs; (2) testing health 

messages, strategies, and program 

components while they are in 

developmental form to assess audience 

comprehension, reactions, and 

perceptions, as well as after they have 

been disseminated to consumers; and 

(3) adding to the tobacco control, public 

health communication, and regulatory 

science knowledge base. Quantitative 

studies play an important role in 

exploring areas of research and 

gathering information because they can 

be used to summarize a population of 

interest on key variables or reveal 

systematic relationships between 

variables. 

This foundational research has helped 

FDA to understand audiences and 

inform message development and the 

testing of messages in communicating 

the risks of tobacco use, how to quit 

using tobacco products, and FDA’s role 

in regulating tobacco. Obtaining this 

information has allowed FDA to 

improve messages, materials, and 

implementation strategies while 

revisions are still affordable and 

possible. 

The voluntary information collected 

serves the primary purpose of providing 

FDA information about various 

measures of ad performance including, 

but not limited to, message 

comprehension, perceived effectiveness, 

emotional responses and knowledge, 

attitudes, and behavioral intentions to 

assess the ability of messages, 

advertisements, and materials to reach 

and successfully communicate with 

their intended audiences. Additionally, 

this information collection provides 

FDA with insights into how to best 

measure public education message 

performance. Quantitative testing of 

messages and other materials with a 

sample of the target audience allows 

FDA to refine and assess messages, 

advertisements, and materials directed 

at consumers. 

In addition, quantitative information 

is collected under this umbrella by FDA 

to track changes in response to policy 

and regulatory actions and to expand 

the tobacco regulatory science base by 

providing information on changing 

behaviors, knowledge and attitudes 

about tobacco products, including postmarketing surveillance of tobacco 

products. In addition, quantitative 

information is collected by FDA to track 

changes in response to policy and 

regulatory actions and to expand the 

tobacco regulatory science base by 

providing information on changing 

behaviors, knowledge, and attitudes 

about tobacco products, including 

postmarketing surveillance of tobacco 

products. 

In the Federal Register of June 21, 

2024 (89 FR 52055), FDA published a 

60-day notice requesting public 

comment on the proposed collection of 

information. No comments were 

received. 

FDA estimates the burden of this 

collection of information as follows: 

TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1

Activity Number of 

respondents 

Number of 

responses per 

respondents 

Total annual 

responses Average burden per response Total hours 

Screener ............................................ 1,360,000 1 1,360,000 0.083 (5 minutes) ............................. 113,334

Self-Administered Surveys ................ 204,000 1 204,000 0.33 (20 minutes) ............................. 68,000 

Informed Consent/Assent ................. 204,000 1 204,000 0.033 (2 minutes) ............................. 6,800 

Total ........................................... 1,768,000 ........................ ........................ ........................................................... 188,134 

1There are no capital costs or operating and maintenance costs associated with this collection of information. 

Our estimated burden for the 

information collection reflects an 

overall increase of 96,269 hours and a 

corresponding increase of 1,106,692 

responses. We attribute this adjustment 

to the number of study responses used 

during the current approval and now 

estimated for the next 3 years. A greater 

number of quantitative studies will be 

conducted over the next 3 years due to 

the need to develop new creative 

messages and content. 

Recent years have seen a dramatic 

change in media. With the shift to 

digital media, FDA must adapt to 

communicate effectively in a digital 

environment. As digital tobacco use 

prevention/interventions are still in 

their infancy, we must better 

understand the types of digital channels 

available. To impact public health 

outcomes, we need to understand how 

to reach our intended audience. New 

foundational studies are needed 

(including those on digital metrics, 

measurement, and implementation) to 

support activities and initiatives that 

will enable the public to receive 

evidence-based, timely, and clear health 

communication and education. As a 

result, we have adjusted our burden 

estimate and revised the number of 

respondents to the information 

collection. 

Dated: November 19, 2024. 

P. Ritu Nalubola, 

Associate Commissioner for Policy. 

[FR Doc. 2024–27483 Filed 11–22–24; 8:45 am] 

BILLING CODE 4164–01–P 


khammond on DSK9W7S144PROD with NOTICES